People that are receiving cyclosporine, tacrolimus or other agents to forestall graft-versus-host disease article bone marrow transplant will not be suitable for this trial "NCI is dedicated to sharing details in accordance with NIH coverage. For more particulars on how scientific demo facts is shared, accessibility the backlink for the https://teresab332pbl6.answerblogs.com/profile